BIO-Europe Spring® 2016: Strategic unit at MD Anderson forges creative alliances

June 2, 2016
Shara Avis, business development specialist at MD Anderson Cancer Center—a world-renown research center—speaks to Mike Ward, global director of content for Informa Pharma Intelligence's insights portfolio, about how the center's strategic industry ventures unit is connecting companies with the research facility in a new way. During the BIO-Europe Spring partnering conference in Stockholm, Sweden, they discuss what the strategic industry unit has achieved so far and how it is targeting creative alliances to advance cancer therapies.
Previous Video
BIO-Europe Spring® 2016: Seventure Partners targets the microbiome revolution
BIO-Europe Spring® 2016: Seventure Partners targets the microbiome revolution

Eric de la Fortelle, venture partner with Seventure Partners in charge of investments in the Benelux, Scand...

Next Video
BIO-Europe Spring® 2016: Italy's A. Menarini IFR aims to expand into the US and Japan
BIO-Europe Spring® 2016: Italy's A. Menarini IFR aims to expand into the US and Japan

A. Menarini IFR corporate licensing director Giammario Piras speaks to Informa senior editor and writer Ste...